RPRX logo

Royalty Pharma plc (RPRX) Interest expense

annual interest expense:

$0.00$0.00(0.00%)
December 31, 2024

Summary

  • As of today (September 11, 2025), RPRX annual interest expense is $0.00, unchanged on December 31, 2024.
  • During the last 3 years, RPRX annual interest expense has risen by $0.00 (0.00%).

Performance

RPRX Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

quarterly interest expense:

$68.67M+$3.41M(+5.22%)
June 30, 2025

Summary

  • As of today (September 11, 2025), RPRX quarterly interest expense is $68.67 million, with the most recent change of +$3.41 million (+5.22%) on June 30, 2025.
  • Over the past year, RPRX quarterly interest expense has increased by +$19.66 million (+40.10%).
  • RPRX quarterly interest expense is now -0.72% below its all-time high of $69.17 million, reached on June 30, 2019.

Performance

RPRX quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM interest expense:

$266.20M+$19.66M(+7.97%)
June 30, 2025

Summary

  • As of today (September 11, 2025), RPRX TTM interest expense is $266.20 million, with the most recent change of +$19.66 million (+7.97%) on June 30, 2025.
  • Over the past year, RPRX TTM interest expense has increased by +$79.66 million (+42.71%).
  • RPRX TTM interest expense is now -0.89% below its all-time high of $268.57 million, reached on December 31, 2019.

Performance

RPRX TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

RPRX Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year0.0%+40.1%+42.7%
3 y3 years0.0%+46.2%+43.6%
5 y5 years0.0%+100.8%+21.1%

RPRX Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+55.3%at high+44.3%
5 y5-yearat highat lowat high+118.4%at high+88.9%
alltimeall timeat highat low-0.7%+118.4%-0.9%+295.7%

RPRX Interest expense History

DateAnnualQuarterlyTTM
Jun 2025
-
$68.67M(+5.2%)
$266.20M(+8.0%)
Mar 2025
-
$65.26M(-0.8%)
$246.54M(+9.3%)
Dec 2024
$0.00(0.0%)
$65.76M(-1.1%)
$225.51M(+8.9%)
Sep 2024
-
$66.51M(+35.7%)
$207.01M(+11.0%)
Jun 2024
-
$49.01M(+10.8%)
$186.53M(+1.1%)
Mar 2024
-
$44.23M(-6.4%)
$184.47M(-1.5%)
Dec 2023
$0.00(0.0%)
$47.26M(+2.7%)
$187.19M(+0.2%)
Sep 2023
-
$46.03M(-2.0%)
$186.89M(-0.5%)
Jun 2023
-
$46.95M(-0.0%)
$187.83M(-0.0%)
Mar 2023
-
$46.95M(-0.0%)
$187.85M(-0.1%)
Dec 2022
$0.00(0.0%)
$46.95M(-0.0%)
$187.96M(-0.0%)
Sep 2022
-
$46.98M(+0.0%)
$187.98M(+1.4%)
Jun 2022
-
$46.97M(-0.2%)
$185.33M(+5.4%)
Mar 2022
-
$47.06M(+0.2%)
$175.79M(+5.8%)
Dec 2021
$0.00
$46.97M(+6.0%)
$166.14M(+5.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
$44.33M(+18.4%)
$157.01M(+8.9%)
Jun 2021
-
$37.43M(+0.0%)
$144.13M(+2.3%)
Mar 2021
-
$37.41M(-1.1%)
$140.89M(-10.3%)
Dec 2020
$0.00(0.0%)
$37.84M(+20.3%)
$157.06M(-14.0%)
Sep 2020
-
$31.44M(-8.0%)
$182.56M(-17.0%)
Jun 2020
-
$34.19M(-36.2%)
$219.91M(-13.7%)
Mar 2020
-
$53.58M(-15.4%)
$254.89M(-5.1%)
Dec 2019
$0.00(0.0%)
$63.34M(-7.9%)
$268.57M(+30.9%)
Sep 2019
-
$68.80M(-0.5%)
$205.23M(+50.4%)
Jun 2019
-
$69.17M(+2.8%)
$136.43M(+102.8%)
Mar 2019
-
$67.27M
$67.27M
Dec 2018
$0.00(0.0%)
-
-
Dec 2017
$0.00(0.0%)
-
-
Dec 2016
$0.00(0.0%)
-
-
Dec 2015
$0.00
-
-

FAQ

  • What is Royalty Pharma plc annual interest expense?
  • What is the all time high annual interest expense for Royalty Pharma plc?
  • What is Royalty Pharma plc annual interest expense year-on-year change?
  • What is Royalty Pharma plc quarterly interest expense?
  • What is the all time high quarterly interest expense for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly interest expense year-on-year change?
  • What is Royalty Pharma plc TTM interest expense?
  • What is the all time high TTM interest expense for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM interest expense year-on-year change?

What is Royalty Pharma plc annual interest expense?

The current annual interest expense of RPRX is $0.00

What is the all time high annual interest expense for Royalty Pharma plc?

Royalty Pharma plc all-time high annual interest expense is $0.00

What is Royalty Pharma plc annual interest expense year-on-year change?

Over the past year, RPRX annual interest expense has changed by $0.00 (0.00%)

What is Royalty Pharma plc quarterly interest expense?

The current quarterly interest expense of RPRX is $68.67M

What is the all time high quarterly interest expense for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly interest expense is $69.17M

What is Royalty Pharma plc quarterly interest expense year-on-year change?

Over the past year, RPRX quarterly interest expense has changed by +$19.66M (+40.10%)

What is Royalty Pharma plc TTM interest expense?

The current TTM interest expense of RPRX is $266.20M

What is the all time high TTM interest expense for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM interest expense is $268.57M

What is Royalty Pharma plc TTM interest expense year-on-year change?

Over the past year, RPRX TTM interest expense has changed by +$79.66M (+42.71%)
On this page